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Objective: To investigate whether implementation of a celiac disease
(CD)–specific health-related quality of life (HRQOL) questionnaire would
add value to CD follow-up visits; we compared patients’ self-reported CD-
specific HRQOL with the physician’s report provided during a regular CD
follow-up visit in children and young adults.
Methods: A cross-sectional study in the control group of a study on self-
management in CD (CoelKids). Eligible patients had CD for 1 year and
were 25 years or younger. They completed a CD-specific HRQOL
questionnaire (CDDUX) after their regular follow-up visit. Their
physicians were unaware of the present study’s objectives or self-
reported HRQOL. Primary outcome: agreement between physician-
reported and self-reported HRQOL. Secondary outcomes: patient
variables predicting a discrepancy between reports, or a lower HRQOL.
Results: Physician-reported HRQOL was available in 70 of 78 enrolled
patients. The self-reported and physician-reported HRQOL were concordant
in 30 of 70 (K¼ 0.093), 6 of them had a poor self-reported HRQOL. Reports
were discrepant in 40 of 70; all 40 self-reported a poor HRQOL.
Discrepancies occurred more frequently in patients with a disease
duration <9 years (32/40 with discrepant reports were diagnosed <9
years ago vs 17/30 with no discrepancy, P<0.001) and in females (35/40
with discrepant reports were girls versus 16 of 30 with no discrepancy,
P¼ 0.001). Both factors were predictors of a poorer HRQOL.
Conclusions: During regular CD follow-up visits, physicians did not report
a poor HRQOL in 40 of 46 children and young adults with a poor self-
reported HRQOL. This is consistent with previous studies examining other
chronic diseases and supports the implementation of self-reported CD-
specific HRQOL measurements in CD follow-up visits.
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eliac disease (CD) is a chronic immune-mediated systemic
disorder elicited by gluten in genetically susceptible indi-C
viduals, affecting 1% to 3% of the general population (1,2). The
disease is treated with a life-long gluten-free diet (GFD) (1,3).Standard medical care for CD patients consists of an evaluation
of health status, weight, height (in children), GFD adherence, and
CD-specific antibodies in serum (4). Health-related quality of life
(HRQOL) is a more subjective and multidimensional concept
containing physical, emotional, social, and cognitive domains that
may vary over time and place (5,6). Physicians need to be aware of
their patients’ HRQOL to intervene and facilitate improvement. In
previous studies, untreated CD was associated with a reduced
HRQOL, typically followed by an improvement after initiation
of treatment (7–11). Others found that the HRQOL in treated
patients with CD was still lower compared to that of the general
population (12,13), or significantly less in women with CD (11,14–
16). The generic HRQOL instruments used in these studies allowed
for comparison with normative data and across disease populations.ghts reserved.
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Vriezinga et al JPGN  Volume 64, Number 5, May 2017Disease-specific instruments may be more discriminating and
sensitive to small differences and changes (17). In 2008, our
research group designed and validated a CD-specific HRQOL
questionnaire for children and young adults (CDDUX) which has
then been used in research settings in different countries (17–19).
Although CD-specific HRQOL is an accepted outcome within
a research environment, it is often not specifically measured during
actual follow-up visits in clinical practice. Nevertheless, it has been
established that in patients with other chronic diseases, the physician
overestimates the patient’s HRQOL (20–22). This has not yet been
examined in CD. To investigate whether implementation of a CD-
specific HRQOL questionnaire would add value to the follow-up
visits for CD, we compared the self-reported CD-specific HRQOL of
a group of children and young adults with the physician’s report
provided during a regular outpatient follow-up visit for CD.
METHODS
In this cross-sectional study, we took advantage of the
existing control group of the on-going multicenter research project
in the Netherlands, called ‘‘CoelKids.’’
CoelKids
CoelKids aims to evaluate a multidisciplinary, internet-based,
self-management system for CD-affected children and young adults
(25 years) to monitor their disease. CD was diagnosed according to
the ESPGHAN criteria (3). The date of diagnosis was either the date
when small bowel biopsies were performed and/or when positive CD-
specific antibodies were determined. Patients were included in the
study only if CD had been diagnosed for at least 1 year, and after
informed consent was obtained. Exclusion criteria: IgA deficiency,
lack of internet access, and/or difficulty in comprehending the Dutch
questionnaires. Participants were randomized into 2 groups; the self-
management system group with online evaluations of their health, or
the control group, wherein patients receive regular outpatient care for
CD. The control group completed CD-specific HRQOL and GFD
adherence questionnaires after their outpatient consultation. The
study protocol was approved by the Medical Ethical Committee of
the Leiden University Medical Center.
Present Study
We analyzed the HRQOL in the control group of CoelKids
participants attending the outpatient clinic of the Leiden University
Medical Center. The recruitment period was from May 2012 to
August 2013. In order to accurately reflect the attention given to
HRQOL by the physicians during a regular outpatient follow-up
visit for CD, the physicians received no instructions about how to
conduct the HRQOL measurement. Furthermore, they were una-
ware of the study’s objective and the patient’s self-reported
HRQOL. In ‘‘real life’’ physicians do not use a standardized method
to assess HRQOL in patients with CD. Therefore, the physician-
reported HRQOL was extracted from the clinical notes in the
patient’s Electronic Patient Record (EPR) by a well-instructed
author who was blinded to the self-reported HRQOL. The phys-
ician-reported HRQOL was classified as: ‘‘1¼ good’’ if the phys-
ician reported there were no CD-associated problems (eg, ‘‘all is
well, GFD accurately followed without problems’’); ‘‘2¼ bad’’ if
CD-associated problems were reported; or ‘‘0¼ not recorded’’ if the
physician did not refer to the quality of life.
The self-reported HRQOL was measured online using the
CDDUX, validated in Dutch children and adolescents (17). A proxy
version for parents was also available. Thus, the self-reported
HRQOL was either the patient’s own response or his/her parent’s.
The CDDUX consists of 12 questions divided into 3 subscales: Copyright © ESPGHAL and NA
738communication (3 items on feelings about explaining his/her disease),
having CD (3 items on feelings when s/he is offered gluten-containing
food), and diet (6 items on feelings about dietary restrictions, lifelong
aspects) (17). Response options were given on a 5-point Likert Scale
(5¼ very bad; 1¼ very good) (17). The mean score was calculated to
represent an overall evaluation (17). To compare the self-reported
HRQOL with the physician’s report, the self-reported HRQOL was
dichotomized into ‘‘good’’ 3.00; and ‘‘bad’’> 3.00. Reports were
considered discrepant when the dichotomized self-reported HRQOL
and the physician-reported HRQOL mismatched.
The patients’ GFD adherence was assessed using the adapted
Dutch version of a previously validated questionnaire, with scores
ranging from 0 to 3 (23). Patients with scores of 0 to 1 were considered
noncompliant. The remaining patients followed a GFD (either with
errors [score 2] or without errors [score 3]). Patients not adhering to
the GFD (score 0–1) were compared with the others (score 2–3).
Outcomes
The primary outcome was the agreement between the self-
and physician-reported HRQOL. Secondary outcomes: the associ-
ation between a discrepant self- and physician-reported HRQOL
and the following patient variables: sex, patient age, age at diag-
nosis, years since diagnosis, GFD adherence, and whether or not
HRQOL was parent-reported and the relation between the self-
reported HRQOL and the aforementioned patient variables.
Data Management and Statistical Analysis
The participants entered their CDDUX responses into a Web-
based data management application (NEN7510 certified). Data col-
lected from the EPR were added manually. A Kappa value (K) was
computed to assess the agreement between the self- and physician-
reported HRQOL. The t test or chi-square test was used to determine
the association between the aforementioned patient variables and a
discrepant self- and physician-reported HRQOL. A univariate
regression analysis was used to screen for patient variables that
potentially influenced the self-reported HRQOL. Variables reaching
borderline significance (P< 0.10) were selected for further evalu-
ation in a multivariate model with a backward elimination approach.
The P value criteria for inclusion and exclusion were set at 0.05 and
0.10, respectively. This method was repeated for the analysis of the
HRQOL scores on the 3 subscales of the CDDUX (communication,
having CD, and diet). Analyses were performed with SPSS software
(version 20.0, IBM Corp., Armonk, NY).
RESULTS
Patients
The characteristics of the 78 patients are presented in
Table 1. Twelve patients self-reported to be nonadherent to the
GFD: 6 of them consumed normal quantities of gluten (score 0), the
others made small dietary transgressions (5 regularly [score 0], 1
rarely [score 1]). Out of the 66 GFD adherent patients, 1 self-
reported committing a dietary error (score 2). The parent-proxy
version of the CDDUX questionnaire was used by 24 of 78 patients
(mean age 7.8 years, range 2.2–13.3 years). The outpatient con-
sultations were performed by 6 different physicians.
Health-related Quality of Life
Self-reported
In general, the HRQOL of the 78 patients ranged from
‘‘neutral’’ to ‘‘bad,’’ with a mean score of 3.29 on a scale ofSPGHAN. All rights reserved.
www.jpgn.org
TABLE 1. Characteristics of the 78 patients with self-reported and
physician-reported health related quality of life
Age, yr, mean (min-max) 12.5 (2.2–24.5)
Age 18 y, N (%) 13 (16.6)
Female, N (%) 57 (73.1)
Age at diagnosis of CD, y, mean (min-max) 5.3 (1.0–23.4)
Duration of CD, y, mean (min-max) 7.2 (1.0–20.6)
Adherent to the GFD

, N (%) 66 (84.6)
CD¼Celiac disease; GFD¼ gluten-free diet.
GFD score 3 (n¼ 65) or 2 (n¼ 1) measured with the adapted Dutch
version of a validated questionnaire (23).
JPGN  Volume 64, Number 5, May 2017 Health-related Quality of Life in Celiac Disease1–5 (1¼ very good; 5¼ very bad). Significantly better (lower)
scores for the subscale communication than for having CD or diet
(Table 2) were observed. A ‘‘bad’’ or ‘‘very bad’’ HRQOL was
reported by 42 patients. A ‘‘good’’ HRQOL was reported by 10
patients, whereas a ‘‘very good’’ HRQOL was reported by 1. Male
sex, older age, and longer disease duration were identified as
predictors of a better HRQOL (univariate analysis, P¼ 0.007;
0.042 and 0.010 respectively). Sex and disease duration together
explained 16.7% of the variance in HRQOL (Table 3). The other
patient variables did not influence the HRQOL. Predictors of a
better score on the communication subscale were the male sex and
using the parent-proxy questionnaire (B¼ 0.561, SE¼ 0.224, 95%
confidence interval [CI]¼ 0.115–1.007, P¼ 0.014; and B¼ 0.430,
SE¼ 0.215, 95% CI¼ 0.002–0.859, P¼ 0.049), explaining 12.4%
of the variance in the communication score. The only predictor of a
better score on the having CD subscale was a longer disease
duration (B¼0.046, SE¼ 0.015, 95% CI¼0.077 to 0.015,
P¼ 0.004), explaining 10.5% of the variance in scores on this
subscale. A better score on the diet subscale was predicted by a
longer disease duration and the male sex (B¼0.038, SE¼ 0.018,
95% CI¼0.074 to 0.002, P¼ 0.039; and B¼ 0.461,
SE¼ 0.211, 95% CI¼ 0.0400.882, P¼ 0.032), explaining
11.4% of the variance in the score.
Physician-reported
The EPR of 70 of 78 patients contained information based
on which the physician-reported HRQOL could be obtained. Six of
70 reports on HRQOL were interpreted as ‘‘bad’’ because the
physician-detected problems resulting from the GFD. In the remain-
ing 64 patients, no CD-related problems were identified; thus, the
HRQOL was interpreted as ‘‘good.’’ Patient age, age at diagnosis,
duration of disease, sex, and adherence to the GFD did not influence Copyright © ESPGHAL and NA
TABLE 2. Self-reported health-related quality of life

in 78 children and you
questionnaire
HRQOL reported by Total mean (SD) Communication
All participants 3.29 (0.68) 2.59y (0
Patient (N¼ 54) 3.29 (0.73) 2.46y (0
Parent-proxy (N¼ 24) 3.31 (0.57)z 2.90y,z (0
CD ¼ celiac disease; HRQOL ¼ health-related quality of life; SD ¼ standa
A lower score indicating a better HRQOL.
ySignificant difference between the mean score for ‘‘communication’’ and ‘‘
signed rank test P 0.02).
zNo significant difference between the total mean HRQOL score reported by
subscales (independent samples t test P¼ 0.872, 0.694, 0.536, respectively)
(P¼ 0.048).
www.jpgn.orgthe physician-reported HRQOL (P¼ 0.137; 0.701; 0.302; 0.930;
0.444, respectively).
Comparison of Self-reported and Physician-
reported HRQOL
The self-reported HRQOL was dichotomized into ‘‘good’’
for 24 patients and into ‘‘bad’’ for 46 patients. The physician-
reported HRQOL matched the self-reported HRQOL in 30 of
70 cases (K¼ 0.093, Table 4). In the remaining 40 cases, a self-
reported ‘‘bad’’ HRQOL was incongruously reported by the phys-
ician as being ‘‘good.’’ Discrepant reports of HRQOL were sig-
nificantly more frequent in patients who had been diagnosed within
the past 9 years (32/40 patients with discrepant reports diagnosed
within past 9 years vs 17/30 in whom the physician-reported
HRQOL was correct, P< 0.001) and these patients were signifi-
cantly more often female (35/40 patients with discrepant reports
were girls vs 16/30 in whom the physician-reported HRQOL was
correct, P¼ 0.001). Age, age at diagnosis of CD, adherence to the
GFD, and whether or not the HRQOL was assessed by parent-proxy
was similarly distributed among both groups (P¼ 0.197; 0.899;
0.394, and 0.766, respectively).
DISCUSSION
To the best of our knowledge, this is the first study comparing
the CD patients’ self-reported HRQOL against the physician’s
HRQOL reports during a regular outpatient follow-up visit for
CD. Our results indicate that there is an important discrepancy
between these reports because in 57% of the patients, the physician
had a different perception of the patients’ HRQOL than the patient
him/herself. What raises concern is that this occurred among
patients considered to be especially vulnerable: those with a
‘‘bad’’ self-reported HRQOL. Our data show that this problem
occurs significantly more frequently in those who received the
diagnosis within the past 9 years and in female patients, possibly
due to their significantly poorer self-reported HRQOL, especially
for the ‘‘communication’’ subscale, compared to their male counter-
parts (P¼ 0.014). On the other contrary, in patients with a ‘‘good’’
self-reported HRQOL, physicians correctly recognized it as being
‘‘good.’’
The female preponderance in our cohort (73.1%) is a well-
known phenomenon in CD (1). Moreover, the neutral to bad self-
reported HRQOL in our cohort is comparable with the results from
previous studies in the Netherlands (8,17). Therefore, our cohort
may be considered as representative of the HRQOL of children and
young adults with CD in our country. In addition, the improvement
of the HRQOL as the disease duration becomes longer is supportedSPGHAN. All rights reserved.
ng adults with celiac disease using the celiac disease–specific CDDUX
mean (SD) Having CD mean (SD) Diet mean (SD)
.92) 3.62 (0.74) 3.48 (0.87)
.92) 3.64 (0.79) 3.52 (0.92)
.88) 3.57z (0.63) 3.39z (0.74)
rd deviation.
having CD’’ and ‘‘communication’’ and ‘‘diet’’ (related-samples Wilcoxon
patients and parents, nor for the scores on the ‘‘having CD’’ and ‘‘diet’’
borderline significance for the scores on the ‘‘communication’’ subscale
739




B SE 95% CI P B SE 95% CI P
Intercept NAy NA NA NA 2.787 0.308 2.173 to 3.401 <0.001
Age, y 0.028 0.014 0.056 to 0.001 0.042
Age at diagnosis 0.008 0.017 0.027 to 0.043 0.655
Duration of CD 0.038 0.014 0.066 to 0.009 0.010 0.036 0.014 0.063 to 0.008 0.012
Female sexz 0.464 0.166 0.133 to 0.795 0.007 0.442 0.161 0.122 to 0.762 0.007
Voluntary gluten intake 0.141 0.214 0.567 to 0.285 0.513
HRQOL reported by parent-proxy 0.027 0.168 0.307 to 0.361 0.872
CD ¼ celiac disease; CI ¼ confidence interval; HRQOL ¼ health-related quality of life; SE ¼ standard error.
By univariate analysis, patient’s age, duration of CD, and sex were selected as potential predictors for the HRQOL. Using a multivariate model with a
backward elimination approach, the age of the participant was eliminated as a factor influencing HRQOL.
yNA¼ not applicable because each univariate model has different intercepts.
zMale¼ 0, female¼ 1.
Vriezinga et al JPGN  Volume 64, Number 5, May 2017by a previous study (24). The lower HRQOL found in girls has been
previously described in adults (11,14–16), but not in children and/
or adolescents (8,24,25). These studies did not use a validated CD-
specific HRQOL questionnaire, but a generic questionnaire with
(14,25) or without (11,15,16,24) added CD-specific questions. In
our cohort, compliance with the GFD did not influence the self-
assessed HRQOL, as was previously described in Dutch children
whose HRQOL was evaluated in a research setting (7). Never-
theless, this should be interpreted with caution given that a rela-
tively small fraction of patients in our cohort were noncompliant to
the GFD (12/78). In contrast to our results, literature indicates that
parents rate their child’s HRQOL lower than the child does him/
herself (17,18,24). Owing to the design of the larger research project
the present study is part of, we only had either a patient or a parent
report, not both. Excluding the 24 participants with parent-reported
HRQOL gave results similar to those presented in this article.
Furthermore, a recent study with the CDDUX in 214 Spanish
children showed similar parent- and child-reported scores (19).
To address the discrepancy between the self-reported and
physician-reported HRQOL in clinical practice, our results are
consistent with previous studies on children affected by other
chronic diseases (20–22). One meta-analysis has, in fact, demon-
strated that the discrepancies between the physician- and child-
reported quality of life were mainly found in subjective rather than
objective domains (20–22). The CD-specific HRQOL question-
naire CDDUX focuses on the subjective matters (feelings) (17).
Previous studies do not report data on discrepancies between the
physician- and self-reported HRQOL based on patient variables
such as age, disease duration, and sex. Copyright © ESPGHAL and NA
TABLE 4. Comparison of the self-reported and physician-reported
health-related quality of life of 70





Physician-reported Good Bad Total
Good 24 40 64
Bad 0 6 6
Total 24 46 70
HRQOL ¼ health-related quality of life.
In 8 of 78 participants, the physician did not assess the HRQOL, self-
reported HRQOL was good in n¼ 5 and bad in n¼ 3.
740The strength of the present study is the use of a previously
validated CD-specific HRQOL questionnaire. Moreover, the phys-
icians were not informed about the study’s objectives. Thus, a
training effect was excluded, accurately reflecting the attention
given to the HRQOL at a regular CD follow-up encounter. Indeed, it
may be questioned whether each participating physician understood
the concept of HRQOL similarly, as they did not use a standardized
method to assess HRQOL. The physician’s evaluation could have
been obtained prospectively in a standardized manner. Our aim was,
however, to compare the patient’s self-reported HRQOL with the
report provided by the physician during regular follow-up. Because
the latter is typically done without using a standardized method, a
questionnaire for physician-reported HRQOL would not provide us
with an accurate reflection of the attention physicians give to this
topic. In addition, assessing whether the outcome of a physician-
completed HRQOL questionnaire agrees with the real (patient-
reported) HRQOL would not be of much use, as insufficient time
during regular follow-up visits would prevent the physician from
completing such a questionnaire. Consequently, to investigate
whether or not the physician’s understanding of the patient’s
HRQOL is accurate we extracted the physician-reported HRQOL
from his/her clinical notes. One may argue that clinical notes do not
always reflect the physician’s understanding of a patient’s HRQOL.
Even if this were true, the lack of ‘‘poor’’ HRQOL documentation
makes subsequent evaluations difficult and means that measures to
increase the HRQOL are not being initiated. Our study included all
physicians from our institution taking care of celiac children and
young adults. This may have introduced interobserver variability.
This is, however, a good reflection of real life: Some physicians
may see more celiac patients than others and some may be more
focused on HRQOL than others. Nevertheless, we found that the
number of discrepancies was in fact neither influenced by whether
the participant was assessed by a pediatric or adult gastroenterol-
ogist (physician- and self-assessed HRQOL matched in 26/63
participants assessed by a pediatrician vs in 4/7 participants
assessed by an adult gastroenterologist, P¼ 0.42) nor by which
physician assessed the patient (P¼ 0.67, see Supplemental Digital
Content, Table, http://links.lww.com/MPG/A747).
Our decision to include a self-reported CD-specific HRQOL
score of exactly 3.00 in the category with a ‘‘good’’ score may be
somewhat artificial. Including a score of 3.00 (n¼ 2) into the
‘‘bad’’ category, however, gave results similar to those presented
in this article, and when all participants with a ‘‘neutral’’ score
(2.61–3.40, N¼ 24) were excluded from our analysis (17). Measur-
ing the HRQOL in a clinical setting may generate the expectationSPGHAN. All rights reserved.
www.jpgn.org
JPGN  Volume 64, Number 5, May 2017 Health-related Quality of Life in Celiac Diseasethat the physician can improve the HRQOL (6). To achieve this in
CD is challenging, firstly because the GFD is the only effective
treatment for CD, and secondly because of the variety of factors,
which affect the generic HRQOL in chronic illness. To minimize
the negative effect of a GFD and to maximize dietary adherence, it
is, however, important that the physician is aware of the HRQOL of
his/her patient. Patients may benefit from a consultation with a
nutritionist and/or psychologist, or associating with peer-groups. It
is possible that the results on the self-reported HRQOL vary in
different countries. For example, Dutch children and adolescents
with CD who both have a high general HRQOL, experienced a low
to neutral CD-specific HRQOL (17). In contrast, similarly affected
Argentine and Spanish patients had good and neutral CD-specific
HRQOL scores, respectively (18,19). Nevertheless, the Argentine
patients indicated that the CDDUX questionnaire helped them
express difficulties during the physician visit that otherwise would
not have been discussed. Furthermore, their physicians indicated
that the CDDUX helped them detect aspects that required action, for
example, the need to refer to a nutritionist or psychologist (18).
In conclusion, there is a clinically significant discrepancy
between the self-reported and physician-reported HRQOL in CD-
affected children and young adults with a poor self-assessed
HRQOL. Female patients and patients with a more recent diagnosis
more often had these discrepant reports. Our study supports the
implementation of a self-reported CD-specific HRQOL measure-
ment in the clinical follow-up of the patients.
As the standard consultation time allotted for follow-up CD
visits is limited, we suggest using a validated CD-specific HRQOL
questionnaire before physician appointments. Sharing the results of
the questionnaire may improve the patient/parent-doctor communi-
cation and the physicians’ understanding of the needs and priorities
of children and young adults with CD.
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